Literature DB >> 2340524

Frequency and pattern of karyotypic abnormalities in human prostate cancer.

A R Brothman1, D M Peehl, A M Patel, J E McNeal.   

Abstract

The cytogenetic evaluation of 30 cultured primary prostatic cancer specimens obtained during radical prostatectomies of patients with relatively early stage disease is reported. The majority of specimens examined showed a normal male karyotype, 46,XY. Nine samples contained clonally abnormal populations including five specimens which were hyperdiploid (modal range, 65-92 chromosomes), one specimen containing double minute chromosomes, and three containing structural aberrations. Loss of the Y chromosome and a partial trisomy for chromosome 4 was observed in a sample from one patient. Another sample showed a translocation between the long arms of chromosomes 5 and 7. The only tumor obtained from a previously irradiated patient contained no normal cells, a modal chromosome number of 45, loss of chromosomes 2 and Y, and multiple structural rearrangements. The appearance of any clonal cytogenetic abnormality correlated in general with a poorly differentiated state of cancer. A survey of all available previous cytogenetic data on human prostate adenocarcinoma indicated that the loss of chromosomes 1, 2, 5, and Y, the gain of chromosomes 7, 14, 20, and 22, and rearrangements involving chromosome arms 2p, 7q, and 10q are the most common changes observed. This suggests that, although the assignment of a single chromosomal aberration as a marker for early stage prostatic cancer is unlikely, several consistent "hotspots" might be of significance in the etiology of this disease.

Entities:  

Mesh:

Year:  1990        PMID: 2340524

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.

Authors:  S F Huang; S Xiao; A A Renshaw; K R Loughlin; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

2.  Keratin expression: a measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors.

Authors:  D M Peehl; G K Leung; S T Wong
Journal:  Cell Tissue Res       Date:  1994-07       Impact factor: 5.249

3.  Interphase in situ hybridization to disaggregated and intact tissue specimens of prostatic adenocarcinomas.

Authors:  J C Alers; P J Krijtenburg; K J Vissers; S K Krishnadath; F T Bosman; H van Dekken
Journal:  Histochem Cell Biol       Date:  1995-12       Impact factor: 4.304

Review 4.  Molecular and cellular markers for metastatic prostate cancer.

Authors:  C W Rinker-Schaeffer; W B Isaacs; J T Isaacs
Journal:  Cancer Metastasis Rev       Date:  1993-03       Impact factor: 9.264

5.  A better defined medium for human prostate cancer cells.

Authors:  T G Pretlow; G S Ogrinc; S B Amini; C M Delmoro; K F Molkentin; J K Willson; T P Pretlow
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

6.  Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.

Authors:  T Visakorpi; E Hyytinen; A Kallioniemi; J Isola; O P Kallioniemi
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

7.  Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

Authors:  M Colombel; F Symmans; S Gil; K M O'Toole; D Chopin; M Benson; C A Olsson; S Korsmeyer; R Buttyan
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

8.  Chromosome spreading techniques for primary gastrointestinal tumors.

Authors:  K Sasai; R Tanaka; M Kawamura; K Honjo; N Matsunaga; T Nakada; K Homma; H Fujimura
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

Review 9.  Prostate cancer progression. Implications of histopathology.

Authors:  J L Ware
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

10.  Isolation of DNA sequences deleted in lung cancer by genomic difference cloning.

Authors:  I Wieland; M Böhm; S Bogatz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.